You are here

Article info

Article menu
Download PDFPDF
Letter
Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections

Authors

  • Rooshi Nathwani Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • David Kockerling Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Benjamin H Mullish Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Alexander Cole Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Maud Lemoine Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Charalambos Gustav Antoniades Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Mark R Thursz Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Ameet Dhar Division of Digestive Diseases, Imperial College London, London, UK Department of Metabolism, Digestion and Reproduction, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Rooshi Nathwani, Division of Metabolism, Digestion and Reproduction, Imperial College London, London W2 1NY, UK; rooshi.nathwani08{at}imperial.ac.uk
View Full Text

Citation

Nathwani R, Kockerling D, Mullish BH, et al
Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections
Frontline Gastroenterology 2022;13:86-88.

Publication history

  • Received February 17, 2021
  • Revised February 22, 2021
  • Accepted February 24, 2021
  • First published March 11, 2021.
Online issue publication 
January 07, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.